Posts Tagged ‘International’

Vascular Graft (Bypass) Market International 2020 Forecasts Analysis

Vascular Graft (Bypass) Market International 2020 Forecasts Analysis













Dallas, Texas (PRWEB) March 26, 2015

Vascular Grafting is a common and popular procedure of surgically implanting a tissue into a body part to replace or compensate a damaged blood vessels. Usually it is preferred that the tissue used is cut out from someone’s own vein as that reduces the risk of infection. Any synthetic implants are highly disposed to thrombosis or clotting, occlusions and infection caused due to protein and cell adsorption and coagulation activation. When such an instance occurs the tissue implanted has to be operated out or replaced immediately. Newer technologies are being developed by using a unique fibrous composite structure to create small diameter vascular grafts so that implementation of such vascular grafts can curtail the risk of redoing the surgery.

To know further on vascular graft market analysis one can refer to the report (http://www.deepresearchreports.com/113983-toc.html). It provides a complete analysis of the market, industry chain structure and industry overview, policy analysis, news analysis, etc. As a part of the industry chain analysis the report details out the upstream raw materials of Vascular Graft, equipments, client survey, various marketing channels available, proposals and various other related inputs for the buyer. For the technical data part the report analyzes Vascular Graft leading suppliers on capacity, commercial production, manufacturing plants distribution, R&D status, technology sources, and raw materials sources. Some of the important manufacturers covered in this report are- Atrium Medical Corporation, Bard Peripheral vascular, Inc, Vascutek Limited, W. L. Gore, Terumo, Maquet, Junken Medical and Shanghai Suokang. There is a complete profiling of each of this manufacturers along with their production capacity and a cost-price value analysis of the production process. It includes the company’s product offerings along with the specifications. Also key contact information in the company.

Presently there is lot of demand for vascular grafting due to lack of alternatives. It is used widely by the people suffering from diabetes and cardiovascular diseases especially by paitents undergoing dialysis as most of the patients need a synthetic vascular grafts to get access to the arteries for the dialysis process. There is very little competition in this market from other products as there are nearly no alternative available. However there is significant competition among the suppliers for the basic synthetic materials, including PTFE.

But there is immense competition among the manufacturers across the globe for getting a share in the market especially in the US. End-consumers have almost no role to play in the product selection. It is usually the surgeon who selects the product. Thus the marketing team of the manufacturing companies should devise a good promotion plan to target the doctors and specialists in this field. However the market prediction is that the need for vascular grafts will declines as soon as there are non-surgical alternatives such as medicines or other invasive techniques available in the market.

The report deals with analysis of different markets with a special focus on the Chinese market. It outlines various products available, industry trends and countries in which there is a need for the product. Towards the end the report there is a SWOT analysis of the on-going projects, a feasibility check for the investors to understand the risk and rewards on entering and investing in this market, investment return analysis, and development trend analysis. The report has been compiled from inputs provided by various experts of the Vascular Graft Industry and also data gathered from various research surveys conducted among technical experts and market engineers. Order a copy of complete research report at http://www.deepresearchreports.com/contacts/purchase.php?name=113983.

















Follow us on:

Contact's Google Plus














Vocus©Copyright 1997-, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.









Find More Alternate Medicine Press Releases

Carnegie Council Presents “Ethics & International Affairs” Summer 2014 Issue Featuring Articles on Human Rights, Drones, and Much More

Carnegie Council Presents “Ethics & International Affairs” Summer 2014 Issue Featuring Articles on Human Rights, Drones, and Much More











Ethics & International Affairs Journal


(PRWEB) June 16, 2014

Carnegie Council’s journal “Ethics & International Affairs” is pleased to announce the publication of its summer 2014 issue.

This issue features essays by Roger Berkowitz on “Drones and the Question of ‘The Human'” and Alan Sussman on the philosophical foundations of human rights; a special centennial roundtable on “The Future of Human Rights,” featuring Beth A. Simmons, Philip Alston, James W. Nickel, Jack Donnelly, and Andrew Gilmour; a review essay by Jens Bartelson on empire and sovereignty; and book reviews.

The entire issue is free online for a limited time.

Go to http://www.ethicsandinternationalaffairs.org

ESSAYS

Drones and the Question of “The Human”

Roger Berkowitz

In our headlong embrace of drone technology, we are forgetting to ask two basic questions: What is a drone? And what does it mean that the once obvious boundary separating human and machine intelligence is being diminished?

Why Human Rights Are Called Human Rights

Alan Sussman

No one can engage in commerce when deprived of liberty or autonomy. No one can create or imagine or love when consumed by fear. We need human rights to permit ourselves the possibility of being human.

ROUNDTABLE: THE FUTURE OF HUMAN RIGHTS

The Future of the Human Rights Movement

Beth A. Simmons

More than twenty years have passed since the end of the Cold War, and the time when people spoke in triumphal terms of the global success of Western values is now a fading memory. The modern human rights movement is at a critical juncture in its history.

Against a World Court for Human Rights

Philip Alston

A World Court is not just an idea whose time has not yet come. The very idea fundamentally misconceives the nature of the challenges confronting an international community dedicated to eliminating major human rights violations

What Future for Human Rights?

James W. Nickel

The field of human rights covers many different beliefs, norms, institutions, and activities, and these may well have different futures. Some may flourish while others wither—along with the social movements that support them.

State Sovereignty and International Human Rights

Jack Donnelly

An increasingly robust international politics of human rights will provide valuable support to domestic advocates, help to impede backsliding, and in at least a few cases decisively tip the balance in favor of human rights at moments of transition.

The Future of Human Rights: A View from the United Nations

Andrew Gilmour

It is with respect to human rights that the UN has experienced some of its greatest shortcomings. The new “Rights up Front” plan may help remedy that deficiency.

REVIEW ESSAY

From Empire to Sovereignty—and Back?

Jens Bartelson

How do empires and sovereign states relate, conceptually as well as historically? It is no coincidence that many historians of political thought are in the process of rewriting the history of sovereignty in light of its changing status.

REVIEWS

Climate Matters: Ethics in a Warming World by John Broome

Review by Dale Jamieson

This book greatly contributes to our attempts to meet the challenge of climate change and to answer the difficult questions that it raises.

Global Justice and Avant-Garde Political Agency by Lea Ypi

Review by Tom Bailey

In this book, Ypi proposes that theory begin with a specific political conflict, diagnose the failure of existing practices and norms to resolve it, and, in this light, develop better practices and norms.

Fairness in Practice: A Social Contract for a Global Economy by Aaron James

Review by Simon Cotton

This book brings political economy, international relations, and development economics into conversation with moral philosophy, making a critical contribution to the ethics of globalization.

Founded by Andrew Carnegie in 1914, Carnegie Council for Ethics in International Affairs is an educational, nonprofit, nonpartisan organization that produces lectures, publications, and multimedia materials on the ethical challenges of living in a globalized world. To learn more, go to http://www.carnegiecouncil.org.






















Vocus©Copyright 1997-, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.









Royal College of Alternative Medicine (RCAM) launches International Fellowship Programme, exclusively designed by it’s Distinguished Emeritus Professor, Dr Joseph Chikelue Obi

(PRWEB) August 28, 2004

Royal College of Alternative Medicine (RCAM) currently has International Vacancies for 1000 ‘Foundation Fellows’ (‘Movers and Shakers’); who will independently play a highly pivotal role in diligently mentoring (and regulating) it’s future Global Membership.

So if you really think that you seriously have what it takes to become a ‘Leader’ in Alternative Medicine , then (perhaps) RCAM may definitely be exactly what the Doctor ordered for you.

Current Requirements for Fellowship as at the 1st of September 2004 are:

*15 Years Experience in Complementary and Alternative Medicine (CAM) ; inclusive of any time spent in Training.

*Membership of a Recognized Professional Body which is presently on the ‘Collegiate Scroll’ of Accredited External Organizations.

*Letters of Recommendation from 2 Current Fellows of the Royal College of Alternative Medicine (Ask Provost for more details).

*A ‘Professional Portfolio’ of ’12 Unique Cases’ in Complementary and Alternative Medicine (CAM) for future publication in the RCAM e-Journal.Each ‘Unique Case’ must be appropriately presented in ‘Microsoft Word Format’ and should (preferably) include diagrams , photographs , references , an honest word count (minimum 500) and all other relevant supporting data.

*A Life-Time (One-Off) ‘Fellowship Fee’ of Euros 2999 (Two Thousand , Nine Hundred and Ninety-Nine Euros).

Please note that as from January the 1st 2005 the size of the ‘Professional Portfolio’ will regretfully increase to ’24 Unique Cases’; together with a considerable increase in the ‘Life-Time Fellowship Fee’.

Those not meeting ‘Fellowship Grade’ will temporarily be ‘quarantined’ in the ‘Fellowship Cadet Club’ ; until a time at which all of the necessary Fellowship Requirements are comprehensively met.

All Fellows of the Royal College of Alternative Medicine shall appropriately be designated FRCAM (Dublin) ; and will be publicly listed in the ‘Register of Fellows’ of the College.They will also be expediently assisted with any Regulatory and Revalidation issues ; and shall be eligible to democratically contest elections for the highly influential position of ‘Chancellor of the Royal College of Alternative Medicine’.

‘Cadet Fellows’ will not be designated ; until they stringently meet all of the necessary Fellowship Requirements.

Please kindly feel free to e-mail any further enquiries and suggestions to Professor Joseph Chikelue Obi (RCAM Provost) at : Provost@RoyalCAM.org

Applications for Fellowship are ethically processed throughout the year ; and an Accelerated Fellowship Programme is also available for any ‘Exceptional Candidates’ who are in honest possession of considerably much more than the required number of ‘Unique Cases’ , but do not have up to 15 Years of Chronological CAM Experience.

About Royal College of Alternative Medicine

RCAM (Royal College of Alternative Medicine) is an Officially Registered, Dublin-Based, Independent, Regulatory, Training and Empowerment Body for Qualified Wellness Consultants and their Associates from all over the world ; which solely aims to Protect the Public ; by raising Ethical Awareness ( and optimizing Best Professional Standards) in Complementary & Alternative Medicine (CAM).

RCAM has absolutely no links whatsoever with any ‘Royal Entity’ of ‘Similar’ (or ‘Presumed Similar’) Nomenclature , Title , Calling , Being or Eminence.

###



International Malaria Research Consortium Combines Technologies and Expertise From Two Continents to Tackle Deadly Disease


xml:lang=”en” lang=”en” xmlns=”http://www.w3.org/1999/xhtml”>

International Malaria Research Consortium Combines Technologies and Expertise From Two Continents to Tackle Deadly Disease







Toronto, ON (Vocus) October 27, 2010

Research teams from three academic institutions and two private sector companies on two continents have come together to form the “International Malaria Research Consortium for the development of novel classes of antimalarials” ,(the “Consortium”) a bold initiative to develop novel classes of drugs against malaria, a deadly disease in desperate need of new treatments.

Each of the Consortium’s five partners brings unique capabilities spanning the spectrum from academic research to commercial development, and significantly – their existing technologies to the table. Through an extensive program design process, the parties hit upon unique combinations of these existing technologies that, combined with new drugs to be developed under the program, represent entirely new approaches to treating and potentially even eradicating this disease.

‘It was a fascinating process to see different organizations with deep knowledge in their individual fields coming together and combining this knowledge to create innovative new approaches to the treatment of this disease’’ – Prof. Virander Chauhan, Director, International Center for Genetic Engineering and Biotechnology-New Delhi

“Creative leverage” is a term that comes to mind in describing this program. Iin addition to developing new therapeutics, we are also bringing together existing technologies developed by the partners and combining them in new ways such that one will have the potential to boost the effectiveness of another.” – Dr. Lakshmi P. Kotra, Director, Center for Molecular Design and Preformulations, University Health Network and University of Toronto.

In a field that has seen very few new drugs introduced in the past 30 years, and where most of these drugs have lost effectiveness due to the emergence of drug resistant malaria strains, this program endeavors to develop entirely new classes of drugs, and furthermore will seek to develop drugs that, by their design, will hinder the emergence of drug resistance.

With funding from the International Science and Technology Partnerships Canada Inc. (ISTPCanada) and the Department of Biotechnology (DBT) of the Government of India, these new therapies will be developed and refined. Led by the site directors of each partner, Lakshmi Kotra at University Health Network/University of Toronto (Consortium lead in Canada), David Bell at Therapure Biopharma, Jitendra Verma at Lifecare Innovations, Asif Mohammed at the International Center for Genetic Engineering and Biotechnology (Consortium lead in India), and R. Mahesh at Birla Institute of Technology and Science, this program brings together a dynamic and talented groups of world-class scientists for a common cause of advancing basic research discoveries to preclinical development. This consortium brings their combined drug development expertise to the discovery and development of new compounds against targets in the parasite that causes malaria.

Current projects include the development of drugs against three malaria targets that the academic groups have researched extensively. This research is combined with the state-of-the-art tools and expertise in computer modeling, medicinal chemistry, nanoformulations and drug conjugation technologies from the consortium partners to advance potential drugs into IND enabling studies. The consortium has already made excellent progress since its activities started in April, 2010 and looking to expand the scope of the efforts with additional partners to advance the mission to develop clinically viable new antimalarials.

One example of this technology combination process is embodied in an objective to treat a form of malaria that resides in the liver. This form of the disease can re-emerge months or years after the initial infection to cause new illnesses in that individual. Additionally this form of the disease can re-introduce malaria into local populations where it had previously been eliminated – frustrating permanent eradication efforts. To tackle this problem the program will combine new drugs developed with existing technologies designed to deliver drugs to the liver in an effective form.

Other technology harnessed under the program will allow antimalarial drugs to be released slowly over long periods of time. This slow release gives the potential for a “one pill cure” , a long sought after goal in anti-malarial drug development programs as it would allow the most effective utilization of often limited medical resources.

Malaria is one of humanities most devastating illnesses with an estimated 247 million cases worldwide in 2008 and almost one million deaths, mostly among children. In Africa a child dies every 45 seconds of Malaria and the disease accounts for 20% of all childhood deaths. Furthermore drug resistance is steadily undermining the effectiveness of existing treatments – driving the need for new therapies.

About Therapure Biopharma

Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies, and packages therapeutic proteins. Therapure Biopharma is also a specialist in therapies derived from hemoglobin, a blood protein. As a contract development and manufacturing organization (CDMO)

Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market.

About University Health Network

University Health Network consists of Toronto General, Toronto Western and Princess Margaret Hospitals. The scope of research and complexity of cases at University Health Network has made it a national and international source for discovery, education and patient care. It has the largest hospital-based research program in Canada, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, and genomic medicine. University Health Network is a research and teaching hospital affiliated with the University of Toronto.

About International Centre for Genetic Engineering Biotechnology (ICGEB)

The ICGEB is an autonomous, intergovernmental organization with its headquarters in Trieste, Italy and two other components in New Delhi, India and Cape Town, South Africa; in addition, ICGEB currently has 57 full Member countries. The ICGEB provides a scientific and educational environment of the highest standard and conducts innovative research in life sciences for the benefit of developing countries. It strengthens the research capability of its members through training and funding programs and advisory services and represents a comprehensive approach to promoting biotechnology internationally.

About Birla Institute of Technology & Science (BITS)

The Birla Institute of Technology & Science (BITS), Pilani is an all-India Institute for Higher Education. The research group at BITS has expertise in synthetic chemistry and drug delivery areas with a strong track record of research in medicinal chemistry and drug discovery related areas.

About Lifecare Innovations

Lifecare Innovations is an R&D intensive company specializing in controlled release pharmaceuticals employing an array of novel drug delivery technologie.. Lifecare Innovations is engaged in the development of number of these controlled release drugs in collaboration with national institutions. These are under various stages of development. Predominant among these are a range of antifungals. In addition, in-house developments for commercialization of technologies have led to the successful launch of several drugs in the market by Lifecare Innovations.

Company Contacts:

Thomas Wellner, President and CEO

Therapure Biopharma Inc.

+1 905 286-6204

http://www.therapurebio.com

###





















Vocus©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.






More Alternate Medicine Press Releases

The Leading Physicians of the World and International Association of Chiropractors Will Place Their Top Doctors in this Year’s Edition




(PRWEB) September 28, 2010

The International Association of Chiropractors will be placing their esteemed physician’s on the pages of the highly notable publication, The Leading Physicians of the World. With a mission of representing the globes finest doctors, chiropractors from the IAC will join the ranks with other prestigious physicians from various specialties, and geographical areas.

Selected chiropractors will be representing their city and will be showcasing their full professional biography and areas of expertise. It is a milestone in every doctor’s career, and a handy reference for patients looking for a specialist in their area.

It can be unsettling and painful, dealing with any musculoskeletal condition. Seeing a chiropractor is the first choice for many, but can be overwhelming searching for the right one. A great place to start your search for a Top Chiropractor in your area is the renowned reference, The Leading Physicians of the World. Members of this book and esteemed organization are selected for their outstanding achievements, community contributions, and highest standards for patient care. Here you will be able to view a full profile of every doctor, and also view their subspecialties, education, credentials and contact information.

The Leading Physicians of the World is also available in a searchable online format. To find a Top Chiropractor in your area, visit www.findatopdoc.com and enter your zip code. The results will automatically populate with a top doctor in your area. You will also be able to view each doctor’s biographical information, insurance coverage, and a list of services.

To find out more about The Leading Physicians of the World, or nominate a chiropractor that has made a difference in your life, please visit www.iachiro.org. For more information on finding a top doctor and Leading Physician in your area, visit www.findatopdoc.com.

About The Leading Physicians of the World

Published yearly, and distributed exclusively to members, physicians and healthcare institutions, The Leading Physicians of the World selects the top 1%-2% of each specialty to be featured in their yearly publication.

Representing over 100 different medical specialties in all major markets across the globe The Leading Physicians of the World, allows consumers to browse the biographies of the most distinguished and desired medical professionals from every field.

###





Find More Alternate Medicine Press Releases

Custom Search
Notice!
Information contained in this website is not intended to diagnose, treat, cure nor prevent any disease, diagnose health problems or take the place of medical advice. This data is for information only. None of the statements or data in this website has been evaluated or reviewed by the FDA. Be sure to check with your health care practitioner before utilizing any information contained on this website. No claims are made for the accuracy, efficacy or safety of any information on this website. All information is provided "as is" and is to be used at your own risk.
Medifocus.com,Inc.
Extend your life
BeneviaBenevia
Puritan's Pride Offer Banner
Health to Happiness